News
Regulator receives 1,000 applications from MSME drugmakers on good manufacturing practice compliance
Companies failing to meet GMP standards could face production halts, licence suspensions, or cancellations. India revised the Act governing drug manufacturing to implement WHO-standard GMP practices.
Incorporating emerging technologies like AI in the drug production process has the potential to boost manufacturing efficiency, lower costs, curb drug shortages and speed approval timelines ...
increasing US production of drugs and pharmaceutical ingredients. The order, signed May 5, intends to lower regulatory barriers for companies looking to expand or set up new drug manufacturing ...
This key milestone underpins the Phase 3 readiness of mitazalimab. "The development of an improved commercial-scale process and the successful manufacturing of the Phase 3 GMP drug product batch marks ...
For example, small and medium businesses looking to capitalize upon the mass production method of industrial manufacturing can take a page out of Henry Ford's book and use a simple conveyor belt ...
Tivic Health Systems Inc. (NASDAQ:TIVC), a company specializing in diversified therapeutics, has announced a definitive agreement with Scorpius BioManufacturing for the final GMP manufacturing ...
Continuous manufacturing could be the solution. Unlike batch manufacturing, where drug production is segmented into a series of slow-moving steps, continuous manufacturing relies on a fully ...
Amid a trade war that could strain imports of lifesaving pharmaceuticals, President Donald Trump wants to ease regulations and bolster domestic drug manufacturing. The president signed an order on ...
In a decisive move to strengthen pharmaceutical regulation ... Under the new directive, the interval for Good Manufacturing Practice (GMP) re-inspection of compliant facilities has been reduced from ...
Amneal Pharmaceuticals inked a collaboration deal with syringe maker Apiject that will see the New Jersey-based biopharma boost its production ... efforts to reshore drug manufacturing in the ...
CHENNAI: Concerns are mounting for the global pharmaceutical industry, particularly for Indian drug manufacturers that rely heavily on the US market. Following the White House's earlier ...
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries. According to the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results